Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
November 7, 2011

TriVascular abdominal stent graft gets FDA approval

The US Food and Drug Administration (FDA) has approved TriVasculars' Ovation abdominal stent graft system to treat abdominal aortic aneurysm.

The US Food and Drug Administration (FDA) has approved TriVasculars’ Ovation abdominal stent graft system to treat abdominal aortic aneurysm.

The TriVascular graft system is approved for use in patients with access vessels of less than 7mm in diameter and aortic necks with lengths of at least 7mm and diameters between 15.5mm and 17.4 mm.

The 14F OD low-profile system separates and optimises fixation and seal to treat abdominal aortic aneurysm.

With this approval, the abdominal stent graft system is now available in Europe and US.

Related Companies

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management